
Number of publications published per year by Banz, Yara. (Source : PubMed)

Distribution of publications types for Banz, Yara. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Hepatology
2009

Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Hepatology
2008;48;3

Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
Gastroenterology
2008;134;1

Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation.
Transpl. Int.
2007;20;8
Exploring natural anticoagulation by endothelial cells: a novel in vitro model.
ALTEX
2007;24 Spec No
Endothelial cell protection in xenotransplantation: looking after a key player in rejection.
Xenotransplantation
2006;13;1
Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Xenotransplantation
2005;12;6


Percutaneous catheter thrombectomy device for acute pulmonary embolism: in vitro and in vivo testing.
Radiology
2005;236;3
Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation.
Am. J. Transplant.
2004;4;2
[ See timeline ] [ See all publications ]
means that Banz, Yara has 4 papers cited a least 4 times - methodology
Department of Clinical Research, University of Bern, Bern, Switzerland.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.